Your browser doesn't support javascript.
loading
Combination of a Novel Fusion Protein CD3εζ28 and Bispecific T Cell Engager Enhances the Persistance and Anti-Cancer Effects of T Cells.
Yu, Feng; Gao, Yang; Wu, Yan; Dai, Anran; Wang, Xiaoyan; Zhang, Xiangzhi; Liu, Guodong; Xu, Qinggang; Chen, Dongfeng.
Afiliação
  • Yu F; School of Life Science, Jiangsu University, No. 301 Xuefu Road, Zhenjiang 212013, China.
  • Gao Y; School of Life Science, Jiangsu University, No. 301 Xuefu Road, Zhenjiang 212013, China.
  • Wu Y; School of Life Science, Jiangsu University, No. 301 Xuefu Road, Zhenjiang 212013, China.
  • Dai A; School of Life Science, Jiangsu University, No. 301 Xuefu Road, Zhenjiang 212013, China.
  • Wang X; Department of Gastroenterology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian 223812, China.
  • Zhang X; School of Life Science, Jiangsu University, No. 301 Xuefu Road, Zhenjiang 212013, China.
  • Liu G; Department of Gastroenterology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian 223812, China.
  • Xu Q; School of Life Science, Jiangsu University, No. 301 Xuefu Road, Zhenjiang 212013, China.
  • Chen D; School of Life Science, Jiangsu University, No. 301 Xuefu Road, Zhenjiang 212013, China.
Cancers (Basel) ; 14(19)2022 Oct 09.
Article em En | MEDLINE | ID: mdl-36230871
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article